Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
In recent studies
Treatment with RS-1 promoted significant antitumor responses in a mouse model
Brubacher MB
Functional characterization of CFI-402257
In addition to cell growth
ESI-09 - CAS# 263707-16-0 size:2mg solid In recent studiesESI 09, CAS No. 263707 16 0, is a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC mediated Rap1 activation and Akt phosphorylation, as well as EPAC mediated insulin secretion in pancreatic cells. EPAC1 plays an important role in pancreatic cancer cell migration and invasion, and thus represents a potential target for developing novel therapeutic strategies for pancreatic cancer. Product
US$ 2975.00
US$ 37.71
US$ 178.23
US$ 89.78
US$ 14.39